1soq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1soq.gif|left|200px]]
[[Image:1soq.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1soq |SIZE=350|CAPTION= <scene name='initialview01'>1soq</scene>, resolution 2.10&Aring;
+
The line below this paragraph, containing "STRUCTURE_1soq", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND=
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE= TTR, PALB ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1soq| PDB=1soq | SCENE= }}
-
|RELATEDENTRY=[[1sok|1SOK]], [[1f41|1F41]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1soq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1soq OCA], [http://www.ebi.ac.uk/pdbsum/1soq PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1soq RCSB]</span>
+
-
}}
+
'''Crystal structure of the transthyretin mutant A108Y/L110E solved in space group C2'''
'''Crystal structure of the transthyretin mutant A108Y/L110E solved in space group C2'''
Line 30: Line 27:
[[Category: Olofsson, A.]]
[[Category: Olofsson, A.]]
[[Category: Sauer-Eriksson, A E.]]
[[Category: Sauer-Eriksson, A E.]]
-
[[Category: greek key beta barrel]]
+
[[Category: Greek key beta barrel]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 08:57:40 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 23:44:56 2008''
+

Revision as of 05:57, 3 May 2008

Template:STRUCTURE 1soq

Crystal structure of the transthyretin mutant A108Y/L110E solved in space group C2


Overview

Conformational changes in native and variant forms of the human plasma protein transthyretin (TTR) induce several types of amyloid diseases. Biochemical and structural studies have mapped the initiation site of amyloid formation onto residues at the outer C and D beta-strands and their connecting loop. In this study, we characterise an engineered variant of transthyretin, Ala108Tyr/Leu110Glu, which is kinetically and thermodynamically more stable than wild-type transthyretin, and as a consequence less amyloidogenic. Crystal structures of the mutant were determined in two space groups, P2(1)2(1)2 and C2, from crystals grown in the same crystallisation set-up. The structures are identical with the exception for residues Leu55-Leu58, situated at beta-strand D and the following DE loop. In particular, residues Leu55-His56 display large shifts in the C2 structure. There the direct hydrogen bonding between beta-strands D and A has been disrupted and is absent, whereas the beta-strand D is present in the P2(1)2(1)2 structure. This difference shows that from a mixture of metastable TTR molecules, only the molecules with an intact beta-strand D are selected for crystal growth in space group P2(1)2(1)2. The packing of TTR molecules in the C2 crystal form and in the previously determined amyloid TTR (ATTR) Leu55Pro crystal structure is close-to-identical. This packing arrangement is therefore not unique in amyloidogenic mutants of TTR.

About this Structure

1SOQ is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

The beta-strand D of transthyretin trapped in two discrete conformations., Hornberg A, Olofsson A, Eneqvist T, Lundgren E, Sauer-Eriksson AE, Biochim Biophys Acta. 2004 Jul 1;1700(1):93-104. PMID:15210129 Page seeded by OCA on Sat May 3 08:57:40 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools